share_log

HC Wainwright & Co. Maintains Buy on ChromaDex, Lowers Price Target to $5.5

Benzinga Real-time News ·  Aug 29, 2022 06:10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ChromaDex (NASDAQ:CDXC) with a Buy and lowers the price target from $7 to $5.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment